Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f2
|
ENSMUSG00000030551.7 | nuclear receptor subfamily 2, group F, member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_70362049_70362384 | Nr2f2 | 1623 | 0.247629 | 0.82 | 3.0e-14 | Click! |
chr7_70361365_70362023 | Nr2f2 | 1101 | 0.366899 | 0.70 | 3.2e-09 | Click! |
chr7_70358111_70358502 | Nr2f2 | 97 | 0.948242 | 0.65 | 5.9e-08 | Click! |
chr7_70355060_70355464 | Nr2f2 | 25 | 0.961787 | 0.65 | 6.2e-08 | Click! |
chr7_70369102_70369271 | Nr2f2 | 2451 | 0.184844 | 0.62 | 4.1e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 39.75 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_124441790_124442379 | 34.46 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
662 |
0.65 |
chr19_61225302_61226760 | 22.15 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr14_14350947_14351733 | 18.73 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr3_116321462_116321795 | 18.59 |
Gm29151 |
predicted gene 29151 |
28475 |
0.15 |
chr16_17987771_17988057 | 17.65 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr19_38054215_38055320 | 12.96 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr1_191224278_191225037 | 12.94 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
183 |
0.92 |
chr9_124439906_124440949 | 12.13 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chrX_81070276_81071390 | 11.38 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr10_36507139_36507637 | 10.84 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
19 |
0.99 |
chr13_83884765_83885152 | 10.79 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
6250 |
0.23 |
chr2_65022121_65023287 | 10.79 |
Grb14 |
growth factor receptor bound protein 14 |
78 |
0.98 |
chr8_3493298_3493991 | 10.52 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chr2_105680597_105681214 | 10.11 |
Pax6 |
paired box 6 |
807 |
0.59 |
chr7_43488630_43488974 | 10.04 |
Iglon5 |
IgLON family member 5 |
1273 |
0.21 |
chr8_71569766_71570805 | 9.95 |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
113 |
0.9 |
chr8_26003457_26003759 | 9.68 |
Fnta |
farnesyltransferase, CAAX box, alpha |
968 |
0.42 |
chr10_78747019_78747870 | 9.28 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr10_86778157_86779118 | 9.07 |
Nt5dc3 |
5'-nucleotidase domain containing 3 |
368 |
0.78 |
chr4_20008989_20009244 | 9.02 |
Ttpa |
tocopherol (alpha) transfer protein |
688 |
0.69 |
chr13_55362078_55363351 | 9.01 |
Lman2 |
lectin, mannose-binding 2 |
69 |
0.95 |
chr10_80302176_80302965 | 8.89 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
750 |
0.36 |
chr9_98524875_98525073 | 8.83 |
Gm37113 |
predicted gene, 37113 |
31006 |
0.11 |
chr11_66167741_66168106 | 8.78 |
Gm12296 |
predicted gene 12296 |
112 |
0.88 |
chr8_70659324_70660479 | 8.75 |
Pgpep1 |
pyroglutamyl-peptidase I |
163 |
0.89 |
chr2_149830360_149831343 | 8.70 |
Syndig1 |
synapse differentiation inducing 1 |
8 |
0.86 |
chr8_122281269_122282287 | 8.69 |
Zfpm1 |
zinc finger protein, multitype 1 |
363 |
0.84 |
chr8_77610315_77610937 | 8.65 |
Tmem184c |
transmembrane protein 184C |
27 |
0.75 |
chr4_124881310_124881874 | 8.54 |
Epha10 |
Eph receptor A10 |
693 |
0.52 |
chr14_3948585_3949537 | 8.43 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr1_178529956_178530555 | 8.20 |
Kif26b |
kinesin family member 26B |
1130 |
0.58 |
chr17_80696913_80697198 | 8.00 |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
30969 |
0.18 |
chr7_28693566_28694015 | 7.96 |
Fbxo27 |
F-box protein 27 |
229 |
0.87 |
chr4_87229982_87230757 | 7.82 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
53 |
0.99 |
chr3_104790339_104791400 | 7.70 |
Rhoc |
ras homolog family member C |
1114 |
0.3 |
chr6_51592848_51593089 | 7.68 |
Gm22914 |
predicted gene, 22914 |
28664 |
0.18 |
chr5_32713265_32714499 | 7.65 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr17_56472537_56473329 | 7.42 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr9_95407231_95407870 | 7.41 |
Gm37805 |
predicted gene, 37805 |
89 |
0.92 |
chr15_89498976_89499718 | 7.41 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
276 |
0.79 |
chr4_116016940_116018214 | 7.37 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr3_17787880_17788087 | 7.29 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1938 |
0.32 |
chr6_85068662_85069731 | 7.25 |
Exoc6b |
exocyst complex component 6B |
261 |
0.84 |
chr15_89499752_89500815 | 7.19 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
160 |
0.9 |
chr16_64069102_64069325 | 7.18 |
Gm49627 |
predicted gene, 49627 |
114083 |
0.07 |
chr3_88214175_88214875 | 7.14 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr8_83566512_83566848 | 7.14 |
Ndufb7 |
NADH:ubiquinone oxidoreductase subunit B7 |
9 |
0.95 |
chr14_14349938_14350878 | 7.13 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr1_38987059_38987497 | 7.12 |
Pdcl3 |
phosducin-like 3 |
563 |
0.72 |
chr12_12420593_12421366 | 7.10 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
28364 |
0.24 |
chr16_18629072_18630255 | 7.06 |
Septin5 |
septin 5 |
41 |
0.96 |
chr3_139860895_139861104 | 7.05 |
Gm43678 |
predicted gene 43678 |
48235 |
0.17 |
chr12_102468744_102469733 | 6.92 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
46 |
0.97 |
chr13_12650037_12651101 | 6.86 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr14_5000842_5001422 | 6.86 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr9_73113328_73113512 | 6.84 |
Rsl24d1 |
ribosomal L24 domain containing 1 |
6 |
0.96 |
chr13_69810011_69810610 | 6.79 |
Med10 |
mediator complex subunit 10 |
396 |
0.83 |
chr19_53449312_53449723 | 6.71 |
Mirt1 |
myocardial infarction associated transcript 1 |
1974 |
0.25 |
chr8_10153970_10154180 | 6.64 |
Myo16 |
myosin XVI |
107 |
0.98 |
chr8_36457363_36458468 | 6.63 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr11_59004710_59005049 | 6.53 |
Gm10435 |
predicted gene 10435 |
1969 |
0.16 |
chr13_13393240_13394314 | 6.52 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr13_64369723_64370483 | 6.50 |
Ctsl |
cathepsin L |
203 |
0.89 |
chr9_103146716_103147058 | 6.45 |
Gm37166 |
predicted gene, 37166 |
26519 |
0.13 |
chr5_148398815_148400002 | 6.44 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
383 |
0.89 |
chr3_79628270_79629417 | 6.42 |
Etfdh |
electron transferring flavoprotein, dehydrogenase |
20 |
0.75 |
chr10_81559146_81561402 | 6.41 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr8_111721704_111721865 | 6.41 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
10321 |
0.16 |
chr15_92051315_92051619 | 6.35 |
Cntn1 |
contactin 1 |
302 |
0.92 |
chr4_152273539_152274471 | 6.35 |
Gpr153 |
G protein-coupled receptor 153 |
227 |
0.89 |
chr1_91412682_91413759 | 6.32 |
Hes6 |
hairy and enhancer of split 6 |
2 |
0.96 |
chr3_127304308_127304459 | 6.31 |
Gm42970 |
predicted gene 42970 |
4710 |
0.17 |
chr18_34006863_34007553 | 6.28 |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4a |
242 |
0.92 |
chr10_18743618_18743843 | 6.27 |
Arfgef3 |
ARFGEF family member 3 |
23 |
0.51 |
chr18_84685090_84685924 | 6.22 |
Cndp2 |
CNDP dipeptidase 2 (metallopeptidase M20 family) |
120 |
0.94 |
chr11_6603325_6604219 | 6.16 |
Nacad |
NAC alpha domain containing |
2281 |
0.14 |
chr11_120721167_120722110 | 6.14 |
Rac3 |
Rac family small GTPase 3 |
65 |
0.91 |
chr15_37960550_37961674 | 6.09 |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
9 |
0.92 |
chr12_81630900_81631615 | 6.07 |
Ttc9 |
tetratricopeptide repeat domain 9 |
8 |
0.97 |
chr10_67549265_67549730 | 6.04 |
Ado |
2-aminoethanethiol (cysteamine) dioxygenase |
429 |
0.76 |
chr3_10439292_10440192 | 6.03 |
Snx16 |
sorting nexin 16 |
345 |
0.89 |
chr11_88471971_88472344 | 6.02 |
Gm11510 |
predicted gene 11510 |
38643 |
0.16 |
chr9_20745177_20746309 | 5.97 |
Olfm2 |
olfactomedin 2 |
606 |
0.68 |
chr1_18058125_18058345 | 5.96 |
Gm45784 |
predicted gene 45784 |
34 |
0.91 |
chr1_50927346_50927549 | 5.95 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
72 |
0.98 |
chr16_39984716_39985001 | 5.92 |
Lsamp |
limbic system-associated membrane protein |
263 |
0.95 |
chr3_8510910_8511440 | 5.90 |
Stmn2 |
stathmin-like 2 |
1589 |
0.43 |
chr10_81059624_81060601 | 5.89 |
Sgta |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
3 |
0.94 |
chr9_83925258_83925676 | 5.87 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
317 |
0.59 |
chr10_81472309_81472908 | 5.84 |
Celf5 |
CUGBP, Elav-like family member 5 |
394 |
0.64 |
chr3_116321850_116322026 | 5.82 |
Gm29151 |
predicted gene 29151 |
28165 |
0.15 |
chr14_14345884_14346978 | 5.80 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr12_117345704_117346011 | 5.78 |
Gm5441 |
predicted gene 5441 |
8835 |
0.29 |
chr7_24883912_24885132 | 5.74 |
Rps19 |
ribosomal protein S19 |
111 |
0.92 |
chr5_37028527_37029187 | 5.74 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr1_91539695_91541223 | 5.74 |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
85 |
0.96 |
chr13_113917716_113918082 | 5.73 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr8_92545416_92545576 | 5.71 |
Gm45336 |
predicted gene 45336 |
79729 |
0.09 |
chr3_89320460_89321321 | 5.67 |
Efna3 |
ephrin A3 |
741 |
0.37 |
chr5_35907951_35908424 | 5.66 |
Afap1 |
actin filament associated protein 1 |
4895 |
0.22 |
chr13_54955752_54956048 | 5.66 |
Unc5a |
unc-5 netrin receptor A |
6489 |
0.16 |
chr19_20006032_20006206 | 5.65 |
Gm22684 |
predicted gene, 22684 |
27516 |
0.21 |
chr16_59471439_59472338 | 5.63 |
Riox2 |
ribosomal oxygenase 2 |
66 |
0.97 |
chr10_9674551_9675589 | 5.62 |
Samd5 |
sterile alpha motif domain containing 5 |
138 |
0.95 |
chr18_65521206_65521450 | 5.61 |
Gm30018 |
predicted gene, 30018 |
10473 |
0.12 |
chr14_19808924_19809109 | 5.56 |
Nid2 |
nidogen 2 |
3780 |
0.19 |
chrX_58030199_58030644 | 5.56 |
Zic3 |
zinc finger protein of the cerebellum 3 |
222 |
0.95 |
chr7_64533404_64533751 | 5.54 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr1_50927042_50927323 | 5.50 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
337 |
0.91 |
chr4_142267317_142267565 | 5.46 |
Kazn |
kazrin, periplakin interacting protein |
28040 |
0.2 |
chr3_155403856_155404226 | 5.46 |
Scp2-ps1 |
sterol carrier protein 2, pseudogene 1 |
110400 |
0.07 |
chr8_95351945_95352331 | 5.45 |
Mmp15 |
matrix metallopeptidase 15 |
130 |
0.94 |
chr6_16316868_16317055 | 5.44 |
Gm3148 |
predicted gene 3148 |
79334 |
0.1 |
chr14_65423658_65423809 | 5.43 |
Pnoc |
prepronociceptin |
1427 |
0.44 |
chr2_30647570_30647873 | 5.41 |
9330198N18Rik |
RIKEN cDNA 9330198N18 gene |
18066 |
0.14 |
chr15_78710517_78710815 | 5.39 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
113 |
0.96 |
chr14_68124597_68124977 | 5.39 |
Nefm |
neurofilament, medium polypeptide |
59 |
0.97 |
chr7_4876646_4877556 | 5.38 |
Isoc2a |
isochorismatase domain containing 2a |
52 |
0.93 |
chr3_62603661_62604074 | 5.38 |
Gpr149 |
G protein-coupled receptor 149 |
1093 |
0.65 |
chr7_84605702_84606753 | 5.37 |
Fah |
fumarylacetoacetate hydrolase |
285 |
0.89 |
chr10_63338911_63339659 | 5.36 |
Sirt1 |
sirtuin 1 |
250 |
0.88 |
chr18_57132795_57133268 | 5.36 |
Megf10 |
multiple EGF-like-domains 10 |
59 |
0.97 |
chr14_52316404_52316604 | 5.35 |
Sall2 |
spalt like transcription factor 2 |
181 |
0.88 |
chr4_136835920_136836937 | 5.35 |
Ephb2 |
Eph receptor B2 |
440 |
0.83 |
chr8_79294435_79295571 | 5.33 |
Mmaa |
methylmalonic aciduria (cobalamin deficiency) type A |
66 |
0.57 |
chr2_152741456_152742233 | 5.31 |
Gm14162 |
predicted gene 14162 |
3863 |
0.13 |
chr6_136173009_136173858 | 5.29 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
56 |
0.85 |
chr17_36946782_36947749 | 5.29 |
Rnf39 |
ring finger protein 39 |
2187 |
0.13 |
chr12_99163133_99163660 | 5.29 |
4930474N09Rik |
RIKEN cDNA 4930474N09 gene |
588 |
0.78 |
chr13_18856504_18856675 | 5.29 |
Vps41 |
VPS41 HOPS complex subunit |
11726 |
0.23 |
chr4_85205076_85205505 | 5.28 |
Sh3gl2 |
SH3-domain GRB2-like 2 |
151 |
0.96 |
chr16_43503386_43503551 | 5.23 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
146 |
0.97 |
chr8_64946989_64947925 | 5.22 |
Tmem192 |
transmembrane protein 192 |
203 |
0.55 |
chr17_8802252_8802463 | 5.20 |
Pde10a |
phosphodiesterase 10A |
578 |
0.81 |
chr6_137437919_137438428 | 5.20 |
Gm44258 |
predicted gene, 44258 |
6868 |
0.23 |
chr5_111725288_111725497 | 5.19 |
Gm26897 |
predicted gene, 26897 |
8532 |
0.19 |
chr2_51066696_51066895 | 5.19 |
Rnd3 |
Rho family GTPase 3 |
82299 |
0.1 |
chr4_43669111_43669978 | 5.18 |
Tmem8b |
transmembrane protein 8B |
12 |
0.83 |
chr7_4130711_4131434 | 5.17 |
Ttyh1 |
tweety family member 1 |
65 |
0.94 |
chr7_91261943_91262198 | 5.15 |
Gm24552 |
predicted gene, 24552 |
19075 |
0.18 |
chr17_34655206_34656139 | 5.11 |
Atf6b |
activating transcription factor 6 beta |
4045 |
0.07 |
chr14_116926469_116927236 | 5.11 |
Gpc6 |
glypican 6 |
916 |
0.75 |
chr4_134496569_134497650 | 5.08 |
Paqr7 |
progestin and adipoQ receptor family member VII |
68 |
0.95 |
chr1_161142929_161143092 | 5.08 |
Ankrd45 |
ankyrin repeat domain 45 |
243 |
0.86 |
chr1_39367675_39368441 | 5.07 |
Rpl31 |
ribosomal protein L31 |
91 |
0.96 |
chr11_35878099_35878297 | 5.07 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
2486 |
0.31 |
chr16_85801841_85802007 | 5.05 |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
443 |
0.86 |
chr14_72869594_72869745 | 5.04 |
Gm4606 |
predicted gene 4606 |
6114 |
0.23 |
chrX_134686235_134686690 | 5.03 |
B230119M05Rik |
RIKEN cDNA B230119M05 gene |
0 |
0.52 |
chr2_174109835_174111101 | 5.02 |
Npepl1 |
aminopeptidase-like 1 |
119 |
0.96 |
chr7_44593726_44594565 | 5.00 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr2_32741230_32742294 | 5.00 |
Sh2d3c |
SH2 domain containing 3C |
270 |
0.7 |
chr14_13355541_13355692 | 4.99 |
Gm15913 |
predicted gene 15913 |
1536 |
0.5 |
chr18_81830833_81831208 | 4.98 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr17_45734818_45735476 | 4.94 |
F630040K05Rik |
RIKEN cDNA F630040K05 gene |
641 |
0.55 |
chr11_88235236_88235944 | 4.94 |
Gm38534 |
predicted gene, 38534 |
17778 |
0.15 |
chr10_79533095_79534301 | 4.93 |
Plpp2 |
phospholipid phosphatase 2 |
59 |
0.95 |
chr18_68140582_68141045 | 4.93 |
Gm41764 |
predicted gene, 41764 |
22439 |
0.18 |
chr14_119513370_119513775 | 4.90 |
Gm6212 |
predicted gene 6212 |
130440 |
0.05 |
chr18_5427698_5428226 | 4.89 |
Gm50065 |
predicted gene, 50065 |
57480 |
0.11 |
chr9_110053315_110053992 | 4.88 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr1_9601419_9601839 | 4.87 |
Vxn |
vexin |
430 |
0.77 |
chr9_37453861_37454564 | 4.85 |
Robo3 |
roundabout guidance receptor 3 |
20966 |
0.1 |
chr8_4217407_4217800 | 4.85 |
Prr36 |
proline rich 36 |
144 |
0.9 |
chr4_99459523_99459887 | 4.84 |
Gm12684 |
predicted gene 12684 |
28451 |
0.13 |
chr17_57062013_57062656 | 4.84 |
Crb3 |
crumbs family member 3 |
35 |
0.93 |
chr11_96899438_96899874 | 4.81 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
9102 |
0.09 |
chr3_116329626_116329777 | 4.80 |
Gm29151 |
predicted gene 29151 |
20402 |
0.17 |
chr8_12873206_12874084 | 4.80 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr19_61226764_61227156 | 4.76 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
276 |
0.86 |
chr13_112100671_112101178 | 4.76 |
Gm31104 |
predicted gene, 31104 |
37192 |
0.15 |
chr18_36196641_36196901 | 4.76 |
Nrg2 |
neuregulin 2 |
461 |
0.85 |
chr7_79499248_79499503 | 4.75 |
Mir9-3hg |
Mir9-3 host gene |
651 |
0.51 |
chr12_4038855_4039434 | 4.74 |
Efr3b |
EFR3 homolog B |
229 |
0.92 |
chr7_100862603_100862998 | 4.74 |
Relt |
RELT tumor necrosis factor receptor |
358 |
0.83 |
chr3_107036536_107036751 | 4.74 |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
474 |
0.77 |
chr11_12231499_12232054 | 4.73 |
Gm12002 |
predicted gene 12002 |
82738 |
0.09 |
chr2_130283847_130284573 | 4.72 |
Idh3b |
isocitrate dehydrogenase 3 (NAD+) beta |
205 |
0.85 |
chrY_90770355_90770677 | 4.72 |
Gm47283 |
predicted gene, 47283 |
14222 |
0.16 |
chr9_64606160_64606342 | 4.70 |
Megf11 |
multiple EGF-like-domains 11 |
54208 |
0.14 |
chr8_80738786_80739993 | 4.68 |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
36 |
0.98 |
chr13_15462780_15463366 | 4.67 |
Gli3 |
GLI-Kruppel family member GLI3 |
162 |
0.76 |
chr8_9770805_9770956 | 4.67 |
Gm47312 |
predicted gene, 47312 |
0 |
0.64 |
chr17_35262621_35263779 | 4.66 |
H2-D1 |
histocompatibility 2, D region locus 1 |
104 |
0.88 |
chr6_51592327_51592791 | 4.66 |
Gm22914 |
predicted gene, 22914 |
29073 |
0.18 |
chr7_105481247_105482042 | 4.65 |
Gm45667 |
predicted gene 45667 |
283 |
0.72 |
chr4_12263404_12263560 | 4.65 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr1_63445451_63445797 | 4.64 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
267 |
0.93 |
chr7_37625778_37625969 | 4.64 |
Gm44883 |
predicted gene 44883 |
36765 |
0.15 |
chr1_177322970_177323308 | 4.63 |
Gm38328 |
predicted gene, 38328 |
53787 |
0.11 |
chr13_105294170_105294752 | 4.63 |
Rnf180 |
ring finger protein 180 |
32 |
0.99 |
chr2_59749338_59749707 | 4.63 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
6720 |
0.29 |
chr2_4402412_4402596 | 4.63 |
Frmd4a |
FERM domain containing 4A |
1033 |
0.54 |
chr6_8778296_8778632 | 4.63 |
Ica1 |
islet cell autoantigen 1 |
20 |
0.99 |
chr1_66177864_66178060 | 4.62 |
Map2 |
microtubule-associated protein 2 |
2412 |
0.38 |
chr10_52704168_52704393 | 4.62 |
Gm47624 |
predicted gene, 47624 |
10442 |
0.19 |
chr12_90915906_90916594 | 4.61 |
Gm47688 |
predicted gene, 47688 |
22132 |
0.17 |
chr17_65666401_65667050 | 4.57 |
Gm49867 |
predicted gene, 49867 |
5147 |
0.2 |
chr9_102249239_102249432 | 4.56 |
Gm37260 |
predicted gene, 37260 |
24401 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.3 | 23.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.0 | 11.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.9 | 8.6 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
2.7 | 8.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
2.5 | 10.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.5 | 7.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.4 | 9.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.2 | 11.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.2 | 6.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
2.1 | 4.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
2.0 | 2.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.0 | 15.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.8 | 3.6 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.8 | 3.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 5.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.7 | 10.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.7 | 5.2 | GO:0001757 | somite specification(GO:0001757) |
1.7 | 5.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.7 | 6.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.7 | 5.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.6 | 4.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.6 | 6.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.6 | 4.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.6 | 4.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.5 | 1.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.5 | 4.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.5 | 4.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.5 | 10.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.4 | 4.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.4 | 7.2 | GO:0042637 | catagen(GO:0042637) |
1.4 | 1.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.4 | 4.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.4 | 6.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.4 | 5.4 | GO:0030035 | microspike assembly(GO:0030035) |
1.3 | 4.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.3 | 2.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.3 | 1.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.3 | 5.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.3 | 1.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.3 | 7.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 3.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.3 | 6.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
1.3 | 5.1 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.3 | 10.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.3 | 5.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.2 | 3.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.2 | 4.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 3.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 3.6 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
1.2 | 3.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.2 | 2.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.2 | 4.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.1 | 3.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.1 | 3.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.1 | 7.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.1 | 1.1 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.1 | 4.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 3.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.1 | 3.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.1 | 1.1 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.1 | 5.5 | GO:0021764 | amygdala development(GO:0021764) |
1.1 | 3.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.1 | 5.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.1 | 8.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 4.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.0 | 3.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.0 | 3.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.0 | 4.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.0 | 3.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 6.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.0 | 3.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.0 | 4.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.0 | 2.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.0 | 2.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 3.9 | GO:0018343 | protein farnesylation(GO:0018343) |
1.0 | 2.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.0 | 4.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.0 | 3.9 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.0 | 2.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.0 | 3.9 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.0 | 1.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.0 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.0 | 3.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.0 | 2.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 0.9 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.9 | 2.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.9 | 4.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.9 | 2.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.9 | 1.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 4.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 0.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.9 | 8.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 2.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 2.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 8.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 3.7 | GO:0008355 | olfactory learning(GO:0008355) |
0.9 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.9 | 0.9 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.9 | 2.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.9 | 8.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.9 | 3.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.9 | 3.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 2.7 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.9 | 1.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 4.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 2.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.9 | 1.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 2.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.9 | 0.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.9 | 8.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.9 | 3.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 4.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.9 | 1.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.8 | 5.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.8 | 2.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.8 | 5.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.8 | 5.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 4.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.8 | 4.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.8 | 3.2 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 1.6 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.8 | 2.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.8 | 2.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 2.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 1.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 1.6 | GO:0051938 | L-glutamate import(GO:0051938) |
0.8 | 2.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.8 | 3.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 2.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 2.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.8 | 1.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 3.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.8 | 3.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 4.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 2.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.8 | 3.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.8 | 2.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.8 | 5.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.8 | 2.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.7 | 3.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.7 | 15.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.7 | 2.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 1.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.7 | 2.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 2.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.7 | 1.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 3.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 1.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.7 | 2.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 1.4 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.7 | 2.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.7 | 7.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 2.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 2.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 3.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 1.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.7 | 2.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.7 | 1.4 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.7 | 1.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 2.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 2.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 1.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.7 | 2.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.7 | 2.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.7 | 4.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.7 | 1.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.7 | 5.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.7 | 0.7 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.7 | 2.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.7 | 2.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.6 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.6 | 2.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 1.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 8.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 1.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 2.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 3.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 2.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 1.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 1.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.6 | 3.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.6 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 1.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 9.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 1.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 1.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 3.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 2.5 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 26.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.6 | 3.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 3.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 1.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 6.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.6 | 1.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.6 | 1.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 1.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.6 | 1.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 0.6 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.6 | 5.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 2.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.6 | 1.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.6 | 1.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 1.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.6 | 10.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.6 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.6 | 1.8 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.6 | 0.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.6 | 6.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 9.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 5.8 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.6 | 4.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.6 | 2.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.6 | 1.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 2.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 1.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.6 | 2.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.6 | 7.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 1.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 1.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 0.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.6 | 2.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.6 | 1.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 7.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 3.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 11.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.5 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.5 | 1.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.5 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.5 | 1.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 1.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 4.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 1.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 1.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 1.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 2.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 3.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 11.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.5 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 5.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.5 | 1.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.5 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 3.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 2.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 5.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 2.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 1.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 4.0 | GO:0015824 | proline transport(GO:0015824) |
0.5 | 2.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 2.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.5 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 3.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 3.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.5 | 0.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 1.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 4.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.5 | 2.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 0.9 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.5 | 1.4 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 1.9 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.5 | 3.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 0.5 | GO:1990314 | coronary artery morphogenesis(GO:0060982) cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 4.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.5 | 3.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.5 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.5 | 0.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.5 | 12.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 1.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 0.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.3 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 1.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.8 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.4 | 1.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 7.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 6.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 3.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.4 | 3.5 | GO:0021756 | striatum development(GO:0021756) |
0.4 | 3.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 2.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 1.3 | GO:0051036 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
0.4 | 1.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 0.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 0.9 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.4 | 12.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.4 | 0.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 0.9 | GO:0046959 | habituation(GO:0046959) |
0.4 | 1.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 2.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 0.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 2.5 | GO:1902583 | viral mRNA export from host cell nucleus(GO:0046784) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.4 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.3 | GO:0045991 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.4 | 1.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.4 | 1.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 1.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 2.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 2.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 2.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 6.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.4 | 2.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 1.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 0.8 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.4 | 1.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 8.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 1.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 0.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 3.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 2.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 2.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.4 | 1.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.4 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 1.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 3.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.4 | 1.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 0.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 1.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 2.8 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.4 | 0.7 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 16.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 5.6 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 2.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.3 | 2.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 1.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.3 | 4.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 1.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 2.4 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.3 | 1.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 3.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.3 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 1.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 2.9 | GO:0071364 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 0.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 1.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 2.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 1.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 2.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 0.6 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.3 | 2.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 3.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.3 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 3.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 0.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 3.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 0.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.6 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 4.2 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.3 | 1.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 0.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.3 | 2.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.5 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 1.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.3 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 7.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 2.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.3 | 2.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 5.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 0.3 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 2.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.5 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 0.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.3 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 18.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 6.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.3 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.3 | 0.3 | GO:0072102 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) glomerulus morphogenesis(GO:0072102) |
0.3 | 0.8 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 5.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.5 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 1.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 1.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 0.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 6.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 2.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 0.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 2.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.2 | 2.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 2.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.7 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 1.2 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.5 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.2 | 1.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 5.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 1.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 4.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 3.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 2.0 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 3.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 4.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 3.0 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.2 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 1.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.4 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 2.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.4 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 4.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 2.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.2 | 2.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 2.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.9 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 1.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 1.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.7 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 | 1.9 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 1.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 2.8 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.6 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 1.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.8 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.2 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 2.6 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.2 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 0.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.9 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.3 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 7.3 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 0.9 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.2 | 1.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 3.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 1.0 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.6 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 13.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 1.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 1.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.5 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 1.0 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 3.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.4 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0042430 | indole-containing compound metabolic process(GO:0042430) |
0.1 | 1.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.6 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.5 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 2.1 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.1 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.2 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.1 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 1.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 3.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 2.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 0.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.1 | 0.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.5 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 2.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 1.3 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 1.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 3.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.8 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 1.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.6 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 0.1 | GO:2001028 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 1.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.7 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.6 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 1.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.3 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.0 | 0.4 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.5 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.0 | 0.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 1.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 1.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.0 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.0 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.0 | 2.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.0 | 5.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.9 | 5.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.9 | 7.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.8 | 5.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.7 | 10.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.5 | 6.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.4 | 8.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 25.2 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 5.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 4.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.1 | 6.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 4.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.1 | 4.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.1 | 5.3 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 4.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.0 | 3.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.0 | 3.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.9 | 2.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.9 | 3.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 2.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 5.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.9 | 3.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.9 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 2.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.9 | 5.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 6.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 14.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 2.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 2.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 0.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.8 | 7.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 2.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 2.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 3.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 5.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 9.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.7 | 21.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 3.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.7 | 2.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 4.0 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 1.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 1.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 2.9 | GO:0097433 | dense body(GO:0097433) |
0.6 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 3.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 2.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 2.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 1.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 0.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.5 | 3.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 4.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 2.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 1.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 2.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 1.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 3.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 1.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 7.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 2.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 10.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 1.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 2.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 18.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 16.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 0.9 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 11.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 5.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.3 | GO:0036396 | MIS complex(GO:0036396) |
0.4 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 2.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 3.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 12.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 3.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 4.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 6.7 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.9 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.8 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 6.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 32.1 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 2.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 8.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 18.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 8.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 2.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.3 | 2.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 2.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 3.2 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 2.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 1.4 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 3.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 3.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 10.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 7.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 36.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 11.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 2.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.8 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 2.9 | GO:0043205 | fibril(GO:0043205) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 20.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 6.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 5.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 2.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 8.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 10.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 2.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 3.6 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 2.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 4.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 4.1 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 3.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 15.9 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 3.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 2.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 1.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 15.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.5 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 1.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 4.2 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.0 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 62.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.1 | 39.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.3 | 6.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.3 | 6.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.9 | 9.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.9 | 5.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.9 | 5.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.8 | 7.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.8 | 7.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 14.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.8 | 10.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.7 | 6.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.7 | 5.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.6 | 4.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.6 | 4.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.5 | 4.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.4 | 4.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.4 | 4.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.4 | 6.9 | GO:1990254 | keratin filament binding(GO:1990254) |
1.4 | 9.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 9.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.2 | 3.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.2 | 3.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.2 | 10.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.2 | 3.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.2 | 4.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 5.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.1 | 3.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.1 | 6.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.1 | 3.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 4.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.0 | 5.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.0 | 5.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 10.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.0 | 3.0 | GO:0016936 | galactoside binding(GO:0016936) |
1.0 | 4.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 4.0 | GO:0030984 | kininogen binding(GO:0030984) |
1.0 | 7.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 4.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 2.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 6.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.9 | 4.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.9 | 2.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.9 | 3.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 5.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.8 | 3.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.8 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 3.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.8 | 14.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.8 | 1.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 2.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 3.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 3.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 3.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 6.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.8 | 9.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.8 | 2.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.8 | 6.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.7 | 3.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 1.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 2.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.7 | 4.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 2.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 4.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 9.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.7 | 1.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.7 | 2.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 2.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 5.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 2.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 3.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 6.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 1.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 1.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.6 | 2.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 2.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 1.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 2.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 15.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 6.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 1.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.6 | 4.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 1.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 2.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 2.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 3.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.6 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 6.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 1.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 2.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.5 | 2.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 6.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 9.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 4.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 4.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 19.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.5 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 1.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 0.5 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.5 | 2.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 9.8 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 6.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.5 | 1.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 2.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 2.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 3.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 3.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 3.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 3.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 1.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.2 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.4 | 2.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 6.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 12.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 8.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.4 | 1.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 3.5 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 5.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 5.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 1.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 1.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 11.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 1.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 4.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 3.5 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 4.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 2.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 2.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 0.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 4.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 3.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 9.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 6.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 10.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 1.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 4.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.3 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 30.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 0.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 2.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 6.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 2.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 3.5 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 1.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 3.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 0.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 0.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 6.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 7.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 19.9 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 2.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 0.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 1.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 7.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 2.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.5 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 3.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 4.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 2.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 11.9 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 3.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 3.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 3.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 2.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 6.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 3.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.2 | 1.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 3.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.3 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 3.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 4.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.8 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 2.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 2.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 4.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 2.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 8.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 3.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 5.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 2.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 20.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 5.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 3.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 1.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.8 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 1.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 2.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 2.7 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 2.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 9.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 0.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 13.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 11.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 10.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 11.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 11.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 1.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 5.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 7.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 9.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 8.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 8.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 5.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 4.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 2.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 4.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 3.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 4.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 4.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 5.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 16.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 17.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 3.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 21.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 13.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 2.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.2 | 3.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.2 | 14.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.2 | 32.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.0 | 9.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.0 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.7 | 8.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 13.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 10.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 8.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 8.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 6.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 2.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 7.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 2.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 6.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 3.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 0.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 5.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 7.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 17.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 17.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 8.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 4.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 5.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 7.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 8.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 6.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 4.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 3.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 20.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 5.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 3.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 10.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 2.4 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 7.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 8.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 0.3 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 2.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 2.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 4.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 3.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 2.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 2.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 4.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 17.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 7.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 3.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 3.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 5.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 3.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 9.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 2.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 3.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.9 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 2.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 4.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |